Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Anxiolytic properties of endogenously occurring pregnanediols in two rodent models of anxiety

Anxiolytic properties of endogenously occurring pregnanediols in two rodent models of anxiety 213 126 126 2 2 E. Carboni K. W. Gee S. Wieland N. C. Lan Department of Pharmacology College of Medicine, University of California Irvine 92717 Irvine CA USA Department of Pharmacology CoCensys Inc. 213 Technology Drive 92718 Irvine CA USA Abstract Certain endogenously occurring 3α-hydroxylated, 5-reduced pregnane steroids act at a specific site on the GABA A receptor complex (GRC) to modulate the effects of GABA at its receptor. Modulators that potentiate GABA at the GABA A receptor often possess anxiolytic properties. The anxiolytic potential of four 5-reduced, 3α, 20-pregnanediols, differing only in the stereochemical orientation of the steroid A-ring and the 20-hydroxyl group, were tested in the Vogel test following intracerebroventricular (ICV) administration. The effects of these pregnanediols were compared to those of their 20-ketone analogues, 3α-hydroxy-5α-pregnan-20-one (3α,5α-P) and 3α-hydroxy-5 β -pregnan-20-one (3α,5 β -P). All four pregnanediols tested significantly enhanced punished drinking at doses ranging from 10 to 60 µg. The rank order of potency based on the minimum effective dose (MED) observed was 5α-pregnan-3α,20α-diol=5 β -pregnan-3α,20α-diol > 5 β -pregnan-3α,20 β -diol > 5α-pregnan-3α,20 β -diol. 3α,5 β -P and 3α,5α-P enhanced punished responding when administered at 2.5 and 5 µg, respectively. 3 β ,5α-P which is inactive at the GRC was also inactive (up to 100 µg) in the Vogel test. The benzodiazepine control diazepam was efficacious when administered at 2.5 µg. 5α-Pregnan-3α,20α-diol was further tested in the mouse elevated plus-maze model following systemic administration where it was found to be active in a dose range of 10–40 mg/kg IP. These results raise the possibility that in addition to 3α,5α-P and 3α,5 β -P, some of their endogenously occurring pregnanediol metabolites may also influence physiological processes related to anxiety via the GRC. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychopharmacology Springer Journals

Anxiolytic properties of endogenously occurring pregnanediols in two rodent models of anxiety

Psychopharmacology , Volume 126 (2) – Jul 1, 1996

Loading next page...
 
/lp/springer-journals/anxiolytic-properties-of-endogenously-occurring-pregnanediols-in-two-FpRKS6z0j1

References (25)

Publisher
Springer Journals
Copyright
Copyright © 1996 by Springer-Verlag
Subject
Biomedicine; Pharmacology/Toxicology; Psychiatry
ISSN
0033-3158
eISSN
1432-2072
DOI
10.1007/BF02246353
Publisher site
See Article on Publisher Site

Abstract

213 126 126 2 2 E. Carboni K. W. Gee S. Wieland N. C. Lan Department of Pharmacology College of Medicine, University of California Irvine 92717 Irvine CA USA Department of Pharmacology CoCensys Inc. 213 Technology Drive 92718 Irvine CA USA Abstract Certain endogenously occurring 3α-hydroxylated, 5-reduced pregnane steroids act at a specific site on the GABA A receptor complex (GRC) to modulate the effects of GABA at its receptor. Modulators that potentiate GABA at the GABA A receptor often possess anxiolytic properties. The anxiolytic potential of four 5-reduced, 3α, 20-pregnanediols, differing only in the stereochemical orientation of the steroid A-ring and the 20-hydroxyl group, were tested in the Vogel test following intracerebroventricular (ICV) administration. The effects of these pregnanediols were compared to those of their 20-ketone analogues, 3α-hydroxy-5α-pregnan-20-one (3α,5α-P) and 3α-hydroxy-5 β -pregnan-20-one (3α,5 β -P). All four pregnanediols tested significantly enhanced punished drinking at doses ranging from 10 to 60 µg. The rank order of potency based on the minimum effective dose (MED) observed was 5α-pregnan-3α,20α-diol=5 β -pregnan-3α,20α-diol > 5 β -pregnan-3α,20 β -diol > 5α-pregnan-3α,20 β -diol. 3α,5 β -P and 3α,5α-P enhanced punished responding when administered at 2.5 and 5 µg, respectively. 3 β ,5α-P which is inactive at the GRC was also inactive (up to 100 µg) in the Vogel test. The benzodiazepine control diazepam was efficacious when administered at 2.5 µg. 5α-Pregnan-3α,20α-diol was further tested in the mouse elevated plus-maze model following systemic administration where it was found to be active in a dose range of 10–40 mg/kg IP. These results raise the possibility that in addition to 3α,5α-P and 3α,5 β -P, some of their endogenously occurring pregnanediol metabolites may also influence physiological processes related to anxiety via the GRC.

Journal

PsychopharmacologySpringer Journals

Published: Jul 1, 1996

There are no references for this article.